Daniela Weiskopf appointed LJI Assistant Professor
The Weiskopf lab studies how the body battles emerging viruses to prepare for pandemic threats
Lab Weiskopf
Spike protein is a key target for stronger and more persistent T-cell responses-a study of mild and asymptomatic SARS-CoV-2 infection
SARS-CoV-2 Omicron (B.1.1.529) shows minimal neurotropism in a double-humanized mouse model
Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection
Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques.
Immune memory in mild COVID-19 patients and unexposed donors reveals persistent T cell responses after SARS-CoV-2 infection.
Metabolic dysregulation impairs lymphocyte function during severe SARS-CoV-2 infection
Virus-specific stem cell memory CD8+ T cells may indicate a long-term protection against evolving SARS-CoV-2
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
Monovalent SARS-CoV-2 mRNA vaccine does not boost Omicron-specific immune response in diabetic and control pediatric patients
Prior cycles of anti-CD20 antibodies affect antibody responses after repeated SARS-CoV-2 mRNA vaccination
Corrigendum: Cross-reactive humoral and CD4+ T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population
Proportion of Ugandans with pre-pandemic SARS-CoV-2 cross-reactive CD4+ and CD8+ T-cell responses: A pilot study
Cross-reactive humoral and CD4+ T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population
Targets and cross-reactivity of human T cell recognition of common cold coronaviruses
An update on studies characterizing adaptive immune responses in SARS-CoV-2 infection and COVID-19 vaccination
A measles virus-based vaccine induces robust chikungunya virus-specific CD4+ T-cell responses in a phase II clinical trial
The megapool approach to characterize adaptive CD4+ and CD8+ T cell responses
Early antiviral CD4 and CD8 T cell responses are associated with upper respiratory tract clearance of SARS-CoV-2
Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination
Frequency of dengue virus-specific T cells is related to infection outcome in endemic settings
SARS-CoV-2 vaccination enhances the effector qualities of spike-specific T cells induced by COVID-19
Innate and adaptive cell-mediated immune responses to a COVID-19 mRNA vaccine in young children
Rimjhim Agarwal selected as Major Symposium speaker at the American Association of Immunologists’ IMMUNOLOGY2024™ Annual Conference
LJI trainee and 2024 SPARK Award winner to share her infectious disease research on a national stage
LJI scientists reflect on what it means to make the “Highly Cited” list
A record number of LJI researchers have been named to the 2022 list, including two early career scientists
LJI scientists publish first head-to-head comparison of four COVID-19 vaccines
New investigation reveals the strength of T cell, B cell, and antibody responses over time
Lungs of COVID-19 survivors teem with virus-fighting ‘memory’ cells
Even elderly survivors show a strong, persistent immune memory
Q&A with COVID-19 researcher Daniela Weiskopf
Weiskopf reflects on nearly two years of non-stop COVID-19 research—and a recent honor from her native Austria
Moderna COVID-19 vaccine spurs lasting immune response
Immune system memory stays strong 6+ months post-vaccination, similar to responses in recovered COVID-19 patients
A COVID-fighter’s guide to T cells
New LJI review shows how T cells target more than 1,400 sites on SARS-CoV-2
Protective immunity against SARS-CoV-2 could last eight months or more
Why declining antibodies don't spell disaster for long-lasting immunity
Daniela Weiskopf Awarded $1.4 million to Study COVID-19 in Latino Americans
New funding from the National Cancer Institute will let scientists get “whole picture” of the immune response
Exposure to common cold coronaviruses can teach the immune system to recognize SARS-CoV-2
Researchers caution: It is too soon to say whether pre-existing immune cell memory affects COVID-19 clinical outcomes
Even in the worst COVID-19 cases, the body launches immune cells to fight back
International collaboration provides important piece of COVID-19 puzzle
LJI scientists awarded new funding to combat COVID-19
To aid vaccine design, researchers will investigate how a diverse population fights off viral attack
